Browse News
Filter News
Found 6,298 articles
-
Rather than selling, Novartis could spin Sandoz off into its own separate entity with its own listing on a stock exchange.
-
After the spring reductions in the workforce that left thousands of biotech employees searching for jobs, larger companies are, for the most part, moving forward.
-
Global Rare Cancer Drug Market Clinical Trials Report
7/1/2022
Rare cancers or orphan cancers are group of cancer which generally affect so few people that drug development for such diseases is considered unprofitable and neglected by the pharmaceutical companies.
-
Viatris Inc. to Release Second Quarter 2022 Financial Results on August 8, 2022
7/1/2022
Viatris Inc. (NASDAQ: VTRS) plans to release its second quarter 2022 financial results on Monday, August 8 before the open of the U.S. financial markets.
-
scPharmaceuticals Inc. to Host FUROSCIX® (furosemide) 80mg/10mL for Subcutaneous Administration Commercial Day: An Investigational Treatment for Heart Failure Patients
6/30/2022
scPharmaceuticals Inc. today announced that the Company is hosting a virtual investor event on Wednesday, July 13, at 10:00 AM EDT.
-
Orthopedic Bioactive Glass Market Growth 2022-2028: Increasing Incidence Of Musculoskeletal Ailments And Chronic Skeletal Conditions
6/30/2022
The latest market analysis report published by Reports and Data, titled ‘Global Orthopedic Bioactive Glass Market – Forecast to 2028,’ thoroughly examines the Orthopedic Bioactive Glass industry to provide essential data & information for the targeted readers.
-
Oncology Biosimilars Market to Expand Substantially Owing to Technological Innovations During 2017-2025
6/29/2022
Wilmington, Delaware, United States: The global oncology biosimilars market is prophesied in a report by Transparency Market Research finds highly competitive and highly fragmentation owing to presence of strong players in the market.
-
Viral Inactivation Market to See Incredible Growth During the Forecast Period
6/29/2022
Wilmington, Delaware, United States: The growth of the global market viral inactivation hinges on to advancements in the fields of drug development, microbiology, and medication.
-
Trauma and Extremities Market to Record Ascending Growth During the Forecast Period
6/29/2022
Wilmington, Delaware, United States: Trauma and extremities devices include various simple and complex devices, growing at a considerable pace.
-
U.K. Biotechnology & Pharmaceutical Services Outsourcing Market Size to Hit US$ 6.9 Bn by 2030
6/29/2022
The U.S. Biotechnology & Pharmaceutical Services Outsourcing market size was valued at US$ 4.1 billion in 2021 and is expected to hit US$ 6.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.2% from 2022 to 2030.
-
Innovent Announces Phase 1b Study Results of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes Published in Nature Communications
6/28/2022
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), announces that phase 1b study results of mazdutide (IBI362), a glucagon-like peptide-1 (GLP-1) and glucagon receptor dual agonist, in Chinese patients with type 2 diabetes have been published in Nature Communications.
-
Palleon Pharmaceuticals and Henlius Enter into Strategic Collaboration to Develop Bifunctional Sialidase Therapies
6/28/2022
Palleon and Henlius to co-develop Bifunctional HER2-Sialidase and a second bifunctional sialidase to be jointly designed.
-
Biosimilars Market: Rise in Number of Cancer Patients to Boost Market
6/28/2022
Wilmington, Delaware, United States: Biosimilar can be defined as a biologic medical product, which is considered very similar to an already-approved biologic.
-
Oncology Biosimilars Market to Reach US$ 12 Billion by 2032, Blood Cancer to Remain Primary Treatment Category: Fact.MR
6/28/2022
Fact.MR – A Market Research and Competitive Intelligence Provider: The global oncology biosimilars market is expected to surge nearly 3x across the 2022-2032 forecast period, reaching US$ 12 Billion.
-
Drug Discovery Technologies Market Analysis of the Competitive Landscape, with a Forecast for 2031
6/28/2022
Wilmington, Delaware, United States: Drug discovery is the process of discovering new medications for different purposes.
-
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
6/27/2022
Innovent Biologics, Inc. and Eli Lilly and Company, announced that the National Medical Products Administration of China has approved the supplemental New Drug Application for TYVYT® in combination with fluorouracil and platinum-based chemotherapy for the first-line treatment of unresectable, locally advanced, recurrent or metastatic gastric or gastroesophageal junction adenocarcinoma.
-
Prefilled Syringes Market: Increase in Acceptance of Self-care Devices to Drive the Global Market
6/27/2022
Wilmington, Delaware, United States: According to the report, the global prefilled syringes market was valued at US$ 5.6 Bn in 2020 and is projected to expand at a CAGR of 13.9% from 2021 to 2028.
-
A new report by PwC projects that the second half of this year will see a “flurry of deals activity across all areas of the sector.”
-
AbbVie has redeemed a Rare Pediatric Disease Priority Review Voucher for Rinvoq (upadactinib), following its FDA approval for adults with moderately to severely active ulcerative colitis in March.
-
Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine
6/24/2022
Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine.